Skip to main content
OpenTrials

Clinical trial condition

Hyperlipidemias

Explore clinical trials studying Hyperlipidemias. Study availability and eligibility vary by location and protocol.

1,231 public trials 93 recruiting studies
Refine in advanced search Browse all conditions

Hyperlipidemias trial results

Completed

A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia

NCT05355402

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +10 more
Locations
  • Clinical Trials Research Lincoln, California, United States
  • Catalina Research Institute, LLC Montclair, California, United States
  • Excel Medical Clinical Trials, LLC Boca Raton, Florida, United States
  • De La Cruz Research Center Miami, Florida, United States
View all 24 locations
View Trial Details
Completed

A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting

NCT05362903

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +8 more
Locations
  • Novartis Investigative Site Freudenstadt, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Heidelberg, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Kirchheim unter Teck, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Konstanz, Baden-Wurttemberg, Germany
View all 121 locations
View Trial Details
Completed

Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia

NCT05192941

Conditions
Angina Pectoris, Arterial Occlusive Diseases, Arteriosclerosis, +18 more
Locations
  • Novartis Investigative Site Sofia, Bulgaria
  • Novartis Investigative Site Burgas, Bulgaria
  • Novartis Investigative Site Burgas, Bulgaria
  • Novartis Investigative Site Gabrovo, Bulgaria
View all 136 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018/CORALreef AddOn)

NCT06450366

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations
  • Clinical Trials Research ( Site 1509) Lincoln, California, United States
  • Healthcare Research Network - Chicago ( Site 1507) Flossmoor, Illinois, United States
  • L-MARC Research Center ( Site 1501) Louisville, Kentucky, United States
  • Velocity Clinical Research Rockville ( Site 1503) Rockville, Maryland, United States
View all 35 locations
View Trial Details
Completed

Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia

NCT04720534

Conditions
Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
Locations
  • Research Site 2 Beverly Hills, California, United States
  • Research Site 4 Palm Springs, California, United States
  • Research Site 5 Boca Raton, Florida, United States
  • Research Site 6 Fort Lauderdale, Florida, United States
View all 74 locations
View Trial Details

Related conditions